Seroatlas · Human Serome Atlas

FBXO39

F-box only protein 39

Also known as: CT144, Fbx39, FBX39_HUMAN, MGC35179

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q8N4B4
Gene
FBXO39
Ensembl
ENSG00000177294
Chromosome
17
Canonical length
442 aa
Protein class
Predicted intracellular proteins

OverviewNCBI Gene

Members of the F-box protein family, such as FBXO39, are characterized by an approximately 40-amino acid F-box motif. SCF complexes, formed by SKP1 (MIM 601434), cullin (see CUL1; MIM 603134), and F-box proteins, act as protein-ubiquitin ligases. F-box proteins interact with SKP1 through the F box, and they interact with ubiquitination targets through other protein interaction domains (Jin et al., 2004 [PubMed 15520277]).[supplied by OMIM, Mar 2008]

Canonical amino-acid sequenceUniProt

442 residues, UniProt reviewed canonical sequence.

>Q8N4B4|FBXO39
     1  MDEESELIQP QDQSCWAFLP DLCLCRVFWW LGDRDRSRAA LVCRKWNQMM YSAELWRYRT
    61  ITFSGRPSRV HASEVESAVW YVKKFGRYLE HLEVKFMNPY NAVLTKKFQV TMRGLLSCLS
   121  KSNNRLKSLS IQYLELDRLV WRNSIRSSFI SSLSFFLKKM GKRLDYLNLK GARLTVEQGC
   181  QILDSLSYMR NENVISELNI EDYFSHHLAV YNSPQFKKTM STFHNLVSLN LNYNCISDEL
   241  LENLCENAST LRTINIKCHV HDPHGQVIWG MSWAKLARQA TNLKVNFFFE RIMKYERLAR
   301  ILLQEIPIRS ISLRSCYFSD PDCSMRPTLI DLLPTFRHTL QKLTCEFNNN HESLDEELHL
   361  LIISCRKLFY FKIWAFLDVS FVERILKSQK ERQCALRVFK ARIYTNRYET NEEDKTLQEI
   421  YRKYRKLIES ELSYFVIVYS VM

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against FBXO39 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Unknown
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.25
Highest tissue expression
29 nTPM

Expression across tissuesHPA

Tissue

  • testis: 29 nTPM
  • ovary: 1 nTPM
  • liver: 0.8 nTPM
  • cervix: 0.4 nTPM
  • adipose tissue: 0.3 nTPM
  • fallopian tube: 0.3 nTPM

Single-cell type

  • late spermatids: 727 nCPM
  • early spermatids: 542 nCPM
  • late primary spermatocytes: 19 nCPM
  • thymocytes: 15 nCPM
  • vascular endothelial cells: 6.8 nCPM
  • leydig cells: 5.4 nCPM

Immune cell

  • gdT-cell: 0.1 nTPM
  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • intermediate monocyte: 0 nTPM
  • MAIT T-cell: 0 nTPM

Brain region

  • cerebral cortex: 0.9 nTPM
  • medulla oblongata: 0.9 nTPM
  • midbrain: 0.6 nTPM
  • spinal cord: 0.6 nTPM
  • amygdala: 0.5 nTPM
  • basal ganglia: 0.5 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about FBXO39.

Disease | ImmuneIEDB

Conditions an epitope on FBXO39 was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1
gnomAD pLI
0
gnomAD missense Z
-0.06
DepMap mean gene effect
-0.01
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of FBXO39 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads FBXO39 as an antibody target. Whether an autoantibody or antibody against FBXO39 could matter depends on whether native FBXO39 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

FBXO39 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label FBXO39 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/FBXO39. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...